{"id":231191,"title":"Use of pneumococcal vaccines in adults, including the use of 15-valent and 20-valent conjugate vaccines: NACI public health level recommendations. - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2025-04-18","captureTimestamp":"2025-04-18T19:06:57.516000+00:00","jobId":1,"originalUrl":"https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/public-health-level-recommendations-use-pneumococcal-vaccines-adults-including-use-15-valent-20-valent-conjugate-vaccines.html?wbdisable=false","snippet":"Use of pneumococcal vaccines in adults, including the use of 15-valent and 20-valent conjugate vaccines: NACI public health level recommendations. - Canada.ca Skip to main content Skip to \"About government\" Language selection Français fr / Gouvernement du Canada Search Search…","rawSnapshotUrl":"/api/snapshots/raw/231191","browseUrl":"https://replay.healtharchive.ca/job-1/20250418190657/https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/public-health-level-recommendations-use-pneumococcal-vaccines-adults-including-use-15-valent-20-valent-conjugate-vaccines.html?wbdisable=false#ha_snapshot=231191","mimeType":"text/html","statusCode":200}